Newer treatment modality for chalazion a benign lid swelling

Intralesional 5-Fluorouracil Injection compared with current treatment modalities for the treatment of chalazia: A Randomized Clinical Trial.

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2022/06/043117

Enrollment

150

Registered

2022-06-09

Start date

Unknown

Completion date

Unknown

Last updated

2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H001- Chalazion

Interventions

Intervention1: 5 Flurouracil: use of 0.1 ml 5 Flurouracil intralesionally injection in chalazion ( single injection) Control Intervention1: Triamcinolone acetate: Use of 0.1 ml Triamcinolone acetate

Eligibility

Inclusion criteria

Inclusion criteria: patient presenting with primary chalazion

Exclusion criteria

Exclusion criteria: pregnant females and patient recieved any previous treatment for chalazion

Design outcomes

Primary

Measure	Time frame
Efficacy of 5-FU- % of reduction in size of chalazion and comparison with injection TA/I&CTimepoint: one month	—

Secondary

Measure	Time frame
Complications of all 3 and its comparison Timepoint: One month	—

Countries

India

Contacts

Public ContactHarshdeep Singh Gabba

Sadguru Netra Chikitsalya

harshdeep8204@gmail.com09819658592

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026